Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1737927/000156459021055275/cgc-10q_20210930.htm
February 2023
February 2023
January 2023
December 2022
November 2022
November 2022
November 2022
October 2022
September 2022
September 2022
April 2020
March 2020
March 2020
March 2020
March 2020
February 2020
February 2020
January 2020
January 2020
January 2020
SMITHS FALLS, ON, November 5, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today announces its financial results for the second quarter fiscal 2022 ended September 30, 2021. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
Highlights
• |
Announced plan to acquire the #1 edibles company in North America, Wana Brands, upon U.S. THC permissibility further strengthening U.S. ecosystem. |
• |
Delivered a robust innovative new product pipeline with over 40+ new SKUs launching globally during Q2 FY2022. |
• |
Launched whisl, an innovative CBD vape designed for mood management, through an exclusive partnership with Circle-K in the U.S. |
• |
Net revenue declined by 3% in Q2 FY2022 versus Q2 FY2021. Maintained market leadership position in premium flower category and increased market share in vapes and edibles during Q2 FY2022 across tracked Canadian recreational cannabis market. |
• |
Pushing out positive Adjusted EBITDA target due to Canada supply challenges and a delayed revenue ramp in the U.S.; taking a number of actions to improve Canadian performance and remain optimistic about the mid-to long-term outlook. |
"In new industries where the potential is immense, progress is rarely a straight line. With a focused strategy, a foundation for growth, and our burgeoning U.S. ecosystem, Canopy is uniquely positioned to win as the industry matures.”
David Klein, Chief Executive Officer, Canopy Growth Corporation
"Achieving profitability remains a top priority. We are focused on increasing market share in Canada, premiumizing our product mix and delivering on our cost savings commitment.”
Mike Lee, Chief Financial Officer, Canopy Growth Corporation
Second Quarter Fiscal 2022 Financial Summary
(in millions of Canadian \dollars, unaudited) |
|
Net Revenue |
Gross margin percentage |
Adjusted gross margin percentage1 |
Net loss |
Adjusted EBITDA2 |
Free cash flow3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported |
|
$131.4 |
(54%) |
(52%) |
$(16.3) |
$(162.6) |
$(101.3) |
vs. Q2 FY2021 |
|
(3%) |
(7,300) bps |
(7,100) bps |
83% |
(90%) |
47% |
1 Adjusted gross margin is a non-GAAP measure, and for Q2 fiscal 2022 excludes $3.1 million related to the flow-through of inventory step-up associated with the acquisition of Supreme Cannabis (Q2 FY2021 - excludes $0.3 million related to the flow-through of inventory step-up associated with fiscal 2020 business combinations). See "Non-GAAP Measures". 2 Adjusted EBITDA is a non-GAAP measure. See "Non-GAAP Measures". 3 Free cash flow is a non-GAAP measure. See "Non-GAAP Measures". |
|
|
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1737927/000156459021055275/cgc-10q_20210930.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Canopy Growth Corp.
Canopy Growth Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
Rating
Learn More![]()
Management calculates Adjusted EBITDA as the reported net income (loss), adjusted to exclude income tax recovery (expense); other income (expense), net; loss on equity method investments; share-based compensation expense; depreciation and amortization expense; asset impairments and restructuring costs; restructuring costs recorded in cost of goods sold; and charges related to the flow-through of inventory step-up on business combinations, and further adjusted to remove acquisition-related costs.
These cost reductions were partially offset by an increase in general and administrative expenses associated with the growth in our business, particularly in relation to our acquisition of Supreme Cannabis in the first quarter of fiscal 2022.
These cost reductions were partially offset by an increase in general and administrative expenses associated with the growth in our business, particularly in relation to our acquisition of Supreme Cannabis in the first quarter of fiscal 2022.
The gross margin was also impacted by the year-over-year reduction in revenue for our Storz & Bickel business, as discussed above in our analysis of net revenue for the second quarter of fiscal 2022, and the resulting shift in the business mix towards an increased revenue contribution from the lower-margin BioSteel business.
The increase of $1.0 million in the current income tax expense arose primarily in connection with legal entities that generated income for tax purposes that could not be reduced by the group's tax attributes.
While we have incurred net...Read more
We undertake no obligation to...Read more
As a result of the...Read more
Comparatively, in the second quarter...Read more
Comparatively, in the six months...Read more
The year-over-year decrease in the...Read more
The year-over-year decreases in the...Read more
In the second quarter of...Read more
In the six months ended...Read more
Our "Adjusted EBITDA" is a...Read more
The year-over-year increase is primarily...Read more
The year-over-year decrease is attributable...Read more
Comparatively, the decrease of $100.5...Read more
Revenue from BioSteel was $7.5...Read more
Revenue from BioSteel was $14.2...Read more
Revenue from This Works was...Read more
Revenue from This Works was...Read more
Our gross margin in the...Read more
Our gross margin in the...Read more
Our gross margin in the...Read more
Our gross margin in the...Read more
Additionally, we incurred higher sponsorship...Read more
Accordingly, management believes that Adjusted...Read more
Management believes that free cash...Read more
These factors were largely offset...Read more
The year-over-year decrease in the...Read more
The year-over-year decrease in the...Read more
Revenue from Storz & Bickel...Read more
The following table presents Adjusted...Read more
The following table presents Adjusted...Read more
The increase of $0.3 million...Read more
Therefore, we are subject to...Read more
Our gross margin in the...Read more
Finally, in the six months...Read more
The effect of this was...Read more
Asset impairments related to periodic...Read more
Additionally, relative to the six...Read more
In the six months ended...Read more
Higher third-party shipping, distribution and...Read more
A variety of factors, including...Read more
This Management's Discussion and Analysis...Read more
Other cannabis revenue was $19.7...Read more
Other cannabis revenue was $11.8...Read more
In connection with certain deferred...Read more
In connection with certain deferred...Read more
There can be no assurance...Read more
These factors were partially offset...Read more
The year-over-year decrease is due...Read more
The year-over-year decrease is due...Read more
The year-over-year decrease is primarily...Read more
The following table presents loss...Read more
The following table presents loss...Read more
These forward-looking statements are generally...Read more
Pursuant to the Acreage Amended...Read more
These expected credit losses and...Read more
As additional consideration for the...Read more
We did not complete any...Read more
Free cash flow is a...Read more
The year-over-year increase in the...Read more
The year-over-year increase in the...Read more
The Accretion Debentures are payable...Read more
Comparatively, the income amount recognized...Read more
The year-over-year decrease is primarily...Read more
The year-over-year decrease is primarily...Read more
The total principal amount owing,...Read more
Charges totaling $91.8 million were...Read more
The expected credit losses reflected...Read more
The year-over-year decrease is primarily...Read more
The decrease of $194.5 million...Read more
The decrease of $510.8 million...Read more
Additional cash inflows during the...Read more
As we rationalized our research...Read more
Increase in interest expense of...Read more
Increase in interest expense of...Read more
Decrease in interest income of...Read more
Additionally, we recorded charges totaling...Read more
Readers are cautioned to consider...Read more
Specifically, the Acreage Amended Arrangement...Read more
These changes were partially offset...Read more
The year-over-year decrease in the...Read more
The year-over-year decrease in the...Read more
The decrease in the cash...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Canopy Growth Corp provided additional information to their SEC Filing as exhibits
Ticker: CGC
CIK: 1737927
Form Type: 10-Q Quarterly Report
Accession Number: 0001564590-21-055275
Submitted to the SEC: Mon Nov 08 2021 4:31:43 PM EST
Accepted by the SEC: Mon Nov 08 2021
Period: Thursday, September 30, 2021
Industry: Medicinal Chemicals And Botanical Products